163074-98-4

Basic information

• Product Name: [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde]
• Synonyms: [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde]
• CAS NO: 163074-98-4
• Molecular Weight: 260.29
• Mol File: 163074-98-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde](CAS DataBase Reference)
• NIST Chemistry Reference: [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde](163074-98-4)
• EPA Substance Registry System: [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde](163074-98-4)

Safety Data

• Hazardous Substances Data: 163074-98-4(Hazardous Substances Data)

Usage

Description

[(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde] is a complex organic compound characterized by a cyclopenta[b]furan core structure and an aldehyde functional group. It is a derivative of a cyclic ketone, featuring a phenylmethoxy group attached to the cyclopenta[b]furan ring. This unique structure and the presence of various functional groups make it a promising candidate for applications in organic synthesis, medicinal chemistry, and potentially the development of novel drugs or agrochemicals.

Uses

Used in Organic Synthesis:
[(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde] is used as an intermediate in organic synthesis for the creation of more complex molecules. Its unique structure and functional groups allow for further chemical modification, making it a versatile building block for the synthesis of various compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde] is used as a starting material for the development of novel drugs. Its complex structure and functional groups offer opportunities for exploring its biological activities and potential therapeutic applications.
Used in Agrochemicals:
[(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde] may also be utilized in the agrochemical industry as a precursor for the development of new pesticides or other agricultural chemicals. Its unique structure could provide new modes of action or improved efficacy in these applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, [(3aR,4R,5R,6aS)-hexahydro-2-oxo-5-(phenylmethoxy)-2H-cyclopenta[b]furan-4-carboxaldehyde] is used as a research compound for exploring its potential as a therapeutic agent. Its complex structure and functional groups may offer new avenues for drug discovery and the development of innovative treatments for various diseases.

Upstream product

• 81190-06-9 [(3aR,4S,5R,6aS)-hexahydro-4-(hydroxymethyl)-5-(phenylmethoxy)-2H-cyclopenta[b]furan-2-one] 
• 32233-40-2 (3aR,4S,5R,6aS)-5-hydroxy-4-(hydroxymethyl)hexahydro-2H-cyclopenta[b]furan-2-one 
• 1236109-24-2 [(3aR,4S,5R,6aS)-hexahydro-5-hydroxy-4(triisopropylsilyloxymethyl)-2H-cyclopenta[b]furan-2-one] 
• 1236109-25-3 (3aR,4S,5R,6aS)-5-(benzyloxy)-4-(((triisopropylsilyl)oxy)methyl)hexahydro-2H-cyclopenta[b]furan-2-one 

Downstream Products

• 1236109-26-4 (3aR,4R,5R,6aS)-4-((E)-4,4-difluoro-3-oxo-1-octenyl)-2-oxo-5-(phenylmethoxy)-hexahydro-2H-cyclopenta[b]furan 
• 333963-40-9 lubiprostone 
• 136790-76-6 13,14-dihydro-15-keto-16,16-difluoro-Prostaglandin E₁ 
• 1236109-27-5 (3aR,4R,5R,6aS)-4-((E)-4,4-difluoro-3-hydroxy-1-octenyl)-5-(phenylmethoxy)-hexahydro-2H-cyclopenta[b]furan-2-ol 
• 1236109-28-6 (Z)-7-[(1R,2R,3R,5S)-2-((E)-4,4-difluoro-3-hydroxy-1-octenyl)-3-(phenylmethoxy)-5-hydroxycyclopentyl]-5-heptenoic acid 
• 1236109-29-7 (Z)-7-[(1R,2R,3R)-2-((E)-4,4-difluoro-3-oxo-1-octenyl)-3-(phenylmethoxy)-5-oxocyclopentyl]-5-heptenoic acid 
• 209860-87-7 tafluprost 

Relevant articles and documents

Method for large-scale preparation of tafluprost

The invention discloses a method for industrially preparing tafluprost. The method comprises the following steps: taking Corey lactone as an initial raw material, oxidizing, condensing, fluorinating,deprotecting, reducing, re-condensing, esterifying and r

METHODS OF MAKING LUBIPROSTONE AND INTERMEDIATES THEREOF

There is provided processes for preparing Lubiprostone and intermediates thereof. Also provided are compounds, including intermediates for preparing Lubiprostone as well as compositions comprising Lubiprostone and other compounds, including intermediates for preparing Lubiprostone and other compounds. (I)